Christopher Henry, MD
Clinical Cardiac Electrophysiology · Arlington Heights, ILNPI 1306073044
Payments from drug & device makers
Across 237 payments — averaging $39.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$2K
- Boston Scientific$1K
- Medical Device Business Services, Inc.$1000
- Biosense Webster, Inc.$774
- Novartis$631
- Abbott$488
- plus $3K from 29 others
What the payments were for
- Speaking & faculty fees$1,80019%
- Travel & lodging$1,22813%
- Food & beverage$6,29667%
- Education$140%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 21 | $2,282 |
| Boston Scientific | 30 | $1,070 |
| Medical Device Business Services, Inc. | 4 | $1,000 |
| Biosense Webster, Inc. | 14 | $774 |
| Novartis | 27 | $631 |
| Abbott | 12 | $488 |
| Pfizer | 19 | $463 |
| Biotronik Inc. | 5 | $354 |
| Amgen | 16 | $330 |
| Boehringer Ingelheim | 12 | $264 |
| Johnson & Johnson | 16 | $215 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 8 | $209 |
| E.r. Squibb & Sons, L.L.C. | 13 | $209 |
| Kestra Medical Technology Services, Inc. | 4 | $162 |
| Edwards Lifesciences | 3 | $121 |
| Abiomed | 3 | $80 |
| Kiniksa Pharmaceuticals International, PLC | 3 | $76 |
| Impulse Dynamics (USA) Inc. | 2 | $71 |
| Lundbeck LLC | 3 | $66 |
| Teleflex LLC | 2 | $51 |
| Sanofi-aventis U.S. LLC | 2 | $48 |
| AstraZeneca | 3 | $47 |
| Altathera Pharmaceuticals LLC | 1 | $44 |
| Regeneron Healthcare Solutions, Inc. | 2 | $44 |
| Stryker | 1 | $41 |
| Cardiva Medical, Inc. | 2 | $35 |
| Cordis US CORP. | 1 | $24 |
| Bayer | 1 | $23 |
| Merck | 1 | $20 |
| Alnylam Pharmaceuticals Inc. | 1 | $20 |
| Cardiovascular Systems Inc. | 1 | $18 |
| Chiesi USA, Inc. | 1 | $18 |
| Terumo Medical Corporation | 1 | $17 |
| Asahi Intecc USA, Inc. | 1 | $15 |
| Arbor Pharmaceuticals, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Carto 3$1,470
- Watchman$293
- Quadra Assura CRT Defibrillator$139
- QDOT MICRO Catheter$132
- NUVISION ICE CATHETER$132
How this compares
$9,337 in reported general payments places this provider in the 25th percentile of 158 clinical cardiac electrophysiology providers in Illinois.
See all clinical cardiac electrophysiology providers in Illinois →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 961 | $1,292,073 |
| XareltoRivaroxaban | 211 | $267,016 |
| EntrestoSacubitril/Valsartan | 55 | $72,658 |
| MultaqDronedarone Hcl | 35 | $50,429 |
| FarxigaDapagliflozin Propanediol | 17 | $28,929 |
| JardianceEmpagliflozin | 15 | $19,799 |
| Dofetilide | 57 | $14,904 |
| Metoprolol Succinate | 606 | $11,745 |
| Flecainide Acetate | 202 | $10,207 |
| Metoprolol Tartrate | 477 | $4,458 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 127 | $4,062 |
| Atorvastatin Calcium | 210 | $2,675 |
| Losartan Potassium | 169 | $2,164 |
| Amiodarone Hcl | 99 | $1,720 |
| SotalolSotalol Hcl | 68 | $1,497 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $463 | $1,292,073961 claims |
| Johnson & JohnsonXarelto | $215 | $267,016211 claims |
| NovartisEntresto | $631 | $72,65855 claims |
| Sanofi-aventis U.S. LLCMultaq | $48 | $50,42935 claims |
| AstraZenecaFarxiga | $47 | $28,92917 claims |
| Boehringer IngelheimJardiance | $264 | $19,79915 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 25th percentile of 158 clinical cardiac electrophysiology providers in Illinois.
Other clinical cardiac electrophysiology in Arlington Heights
- Roderick TungChicago$2.3M
- Bradley KnightChicago$1.6M
- Mark MetzlEvanston$1.5M
- Moeen SaleemNaperville$1.2M
- Ziad IssaSpringfield$1.2M
- Henry HuangGeneva$955K
- Mansour RazminiaPalos Heights$930K
- Gaurav UpadhyayChicago$785K
- William SpearEvergreen Park$675K
- Kousik KrishnanNaperville$517K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.